Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs designed to target Alzheimer's.

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

A new analysis of classical medical texts suggests dementia was extremely rare in ancient Greece and Rome 2,000 to 2,500 ...

Steve Waddell, the founder, president and CEO of Nasoni, recently landed a $2.58 million federal grant to integrate advanced ...

In the period spanning 2017-2021, a mere 12 new antibiotics entered the market, with only one capable of targeting all the ...

Evidence is increasing to show the link between air pollution and the risk of Parkinson’s disease, health experts said on ...

Pueblo Central High School teacher John "Juan" Nava, who was well known for the love and care he showed his students, died ...

Aphios Corporation announced today that it has been granted Japanese Patent No. 7,520,838 for novel compositions to treat folic acid deficiency and morning sickness. The dosage forms have an effective ...

Neurable wants to boost productivity by enhancing focus and concentration with brain-tracking headphones, built in ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that CEO ...

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual meeting of the Society for Neuroscience (SfN) ...

Scientists find microplastics in human brain tissue raising concerns about potential health risks and how these particles infiltrate vital organs ...